Sun Pharmaceutical Industries has rallied 4.5% to Rs 1,040, also its record high on BSE, after reporting a better-than-expected 23% year-on-year (yoy) growth in its consolidated net profit at Rs 1,012 crore for the quarter ended March 31, 2013 (Q4) on back of higher operational income. The company had profit of Rs 820 crore in a year ago quarter.
Total income from operations increased 32% to Rs 3,087 crore from Rs 2,336 crore during the recently concluded quarter.
Analysts on an average had expected the company to report a net profit of Rs 910 crore and net sales of Rs 2,906 crore for the quarter.
Meanwhile, the board has approved bonus issue in the ratio of 1:1 i.e. one share for every one share held on the record date. It has also declared a dividend of Rs 5 per share on face value of Rs 1 each.
Total income from operations increased 32% to Rs 3,087 crore from Rs 2,336 crore during the recently concluded quarter.
Analysts on an average had expected the company to report a net profit of Rs 910 crore and net sales of Rs 2,906 crore for the quarter.
Meanwhile, the board has approved bonus issue in the ratio of 1:1 i.e. one share for every one share held on the record date. It has also declared a dividend of Rs 5 per share on face value of Rs 1 each.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%